English
简体中文
Total: £ 56.28
Published Date: 2025-03-24 | Pages: 85 | Tables: 86 | Pharma & Healthcare
The global market for DPT Vaccines was valued at US$ 5555 million in the year 2024 and is projected to reach a revised size of US$ 7043 million by 2031, growing at a CAGR of 3.5% during the forecast period.
The DPT vaccine or DTP vaccine is a class of combination vaccine against three infectious diseases in humans: diphtheria, pertussis (whooping cough), and tetanus.
Global key DPT vaccines manufacturers include Sanofi Pasteur, GSK etc.The top 2 companies hold a share over 90%.Europe is the largest market, with a share about 34%, followed by North America and Asia-Pacific with the share about 27% and 25%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for DPT Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DPT Vaccines.
The DPT Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global DPT Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Age, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DPT Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Age, and by regions.
By Company
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
Segment by Type
DTaP
Tdap
DTwP
Segment by Age
12 Months Below
12 Months Above
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of DPT Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of DPT Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Age, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 DPT Vaccines Market Overview
1.1 Product Definition
1.2 DPT Vaccines by Type
1.2.1 Global DPT Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 DTaP
1.2.3 Tdap
1.2.4 DTwP
1.3 DPT Vaccines by Age
1.3.1 Global DPT Vaccines Market Value by Age (2024 VS 2031)
1.3.2 12 Months Below
1.3.3 12 Months Above
1.4 Global DPT Vaccines Market Size Estimates and Forecasts
1.4.1 Global DPT Vaccines Revenue 2020-2031
1.4.2 Global DPT Vaccines Sales 2020-2031
1.4.3 Global DPT Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 DPT Vaccines Market Competition by Manufacturers
2.1 Global DPT Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global DPT Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global DPT Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of DPT Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of DPT Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of DPT Vaccines, Product Type & Application
2.7 Global Key Manufacturers of DPT Vaccines, Date of Enter into This Industry
2.8 Global DPT Vaccines Market Competitive Situation and Trends
2.8.1 Global DPT Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest DPT Vaccines Players Market Share by Revenue
2.8.3 Global DPT Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global DPT Vaccines Market Scenario by Region
3.1 Global DPT Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global DPT Vaccines Sales by Region: 2020-2031
3.2.1 Global DPT Vaccines Sales by Region: 2020-2025
3.2.2 Global DPT Vaccines Sales by Region: 2026-2031
3.3 Global DPT Vaccines Revenue by Region: 2020-2031
3.3.1 Global DPT Vaccines Revenue by Region: 2020-2025
3.3.2 Global DPT Vaccines Revenue by Region: 2026-2031
3.4 North America DPT Vaccines Market Facts & Figures by Country
3.4.1 North America DPT Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America DPT Vaccines Sales by Country (2020-2031)
3.4.3 North America DPT Vaccines Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe DPT Vaccines Market Facts & Figures by Country
3.5.1 Europe DPT Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe DPT Vaccines Sales by Country (2020-2031)
3.5.3 Europe DPT Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific DPT Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific DPT Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific DPT Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific DPT Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America DPT Vaccines Market Facts & Figures by Country
3.7.1 Latin America DPT Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America DPT Vaccines Sales by Country (2020-2031)
3.7.3 Latin America DPT Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa DPT Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa DPT Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa DPT Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa DPT Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global DPT Vaccines Sales by Type (2020-2031)
4.1.1 Global DPT Vaccines Sales by Type (2020-2025)
4.1.2 Global DPT Vaccines Sales by Type (2026-2031)
4.1.3 Global DPT Vaccines Sales Market Share by Type (2020-2031)
4.2 Global DPT Vaccines Revenue by Type (2020-2031)
4.2.1 Global DPT Vaccines Revenue by Type (2020-2025)
4.2.2 Global DPT Vaccines Revenue by Type (2026-2031)
4.2.3 Global DPT Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global DPT Vaccines Price by Type (2020-2031)
5 Segment by Age
5.1 Global DPT Vaccines Sales by Age (2020-2031)
5.1.1 Global DPT Vaccines Sales by Age (2020-2025)
5.1.2 Global DPT Vaccines Sales by Age (2026-2031)
5.1.3 Global DPT Vaccines Sales Market Share by Age (2020-2031)
5.2 Global DPT Vaccines Revenue by Age (2020-2031)
5.2.1 Global DPT Vaccines Revenue by Age (2020-2025)
5.2.2 Global DPT Vaccines Revenue by Age (2026-2031)
5.2.3 Global DPT Vaccines Revenue Market Share by Age (2020-2031)
5.3 Global DPT Vaccines Price by Age (2020-2031)
6 Key Companies Profiled
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Company Information
6.1.2 Sanofi Pasteur Description and Business Overview
6.1.3 Sanofi Pasteur DPT Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Pasteur DPT Vaccines Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK DPT Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GSK DPT Vaccines Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Mitsubishi Tanabe Pharma
6.3.1 Mitsubishi Tanabe Pharma Company Information
6.3.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.3.3 Mitsubishi Tanabe Pharma DPT Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Mitsubishi Tanabe Pharma DPT Vaccines Product Portfolio
6.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.4 KM Biologics
6.4.1 KM Biologics Company Information
6.4.2 KM Biologics Description and Business Overview
6.4.3 KM Biologics DPT Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 KM Biologics DPT Vaccines Product Portfolio
6.4.5 KM Biologics Recent Developments/Updates
6.5 Wuhan Institute of Biological Products
6.5.1 Wuhan Institute of Biological Products Company Information
6.5.2 Wuhan Institute of Biological Products Description and Business Overview
6.5.3 Wuhan Institute of Biological Products DPT Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Wuhan Institute of Biological Products DPT Vaccines Product Portfolio
6.5.5 Wuhan Institute of Biological Products Recent Developments/Updates
6.6 Walvax Biotechnology
6.6.1 Walvax Biotechnology Company Information
6.6.2 Walvax Biotechnology Description and Business Overview
6.6.3 Walvax Biotechnology DPT Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Walvax Biotechnology DPT Vaccines Product Portfolio
6.6.5 Walvax Biotechnology Recent Developments/Updates
6.7 Chengdu Institute of Biological Products
6.7.1 Chengdu Institute of Biological Products Company Information
6.7.2 Chengdu Institute of Biological Products Description and Business Overview
6.7.3 Chengdu Institute of Biological Products DPT Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Chengdu Institute of Biological Products DPT Vaccines Product Portfolio
6.7.5 Chengdu Institute of Biological Products Recent Developments/Updates
6.8 Minhai Biotechnology
6.8.1 Minhai Biotechnology Company Information
6.8.2 Minhai Biotechnology Description and Business Overview
6.8.3 Minhai Biotechnology DPT Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Minhai Biotechnology DPT Vaccines Product Portfolio
6.8.5 Minhai Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 DPT Vaccines Industry Chain Analysis
7.2 DPT Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 DPT Vaccines Production Mode & Process Analysis
7.4 DPT Vaccines Sales and Marketing
7.4.1 DPT Vaccines Sales Channels
7.4.2 DPT Vaccines Distributors
7.5 DPT Vaccines Customer Analysis
8 DPT Vaccines Market Dynamics
8.1 DPT Vaccines Industry Trends
8.2 DPT Vaccines Market Drivers
8.3 DPT Vaccines Market Challenges
8.4 DPT Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global DPT Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global DPT Vaccines Market Value by Age (2024 VS 2031) & (US$ Million)
Table 3. Global DPT Vaccines Market Competitive Situation by Manufacturers in 2024
Table 4. Global DPT Vaccines Sales (M Doses) of Key Manufacturers (2020-2025)
Table 5. Global DPT Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 6. Global DPT Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global DPT Vaccines Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market DPT Vaccines Average Price (US$/Dose) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of DPT Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of DPT Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of DPT Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of DPT Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global DPT Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DPT Vaccines as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global DPT Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global DPT Vaccines Sales by Region (2020-2025) & (M Doses)
Table 18. Global DPT Vaccines Sales Market Share by Region (2020-2025)
Table 19. Global DPT Vaccines Sales by Region (2026-2031) & (M Doses)
Table 20. Global DPT Vaccines Sales Market Share by Region (2026-2031)
Table 21. Global DPT Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global DPT Vaccines Revenue Market Share by Region (2020-2025)
Table 23. Global DPT Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global DPT Vaccines Revenue Market Share by Region (2026-2031)
Table 25. North America DPT Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America DPT Vaccines Sales by Country (2020-2025) & (M Doses)
Table 27. North America DPT Vaccines Sales by Country (2026-2031) & (M Doses)
Table 28. North America DPT Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America DPT Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe DPT Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe DPT Vaccines Sales by Country (2020-2025) & (M Doses)
Table 32. Europe DPT Vaccines Sales by Country (2026-2031) & (M Doses)
Table 33. Europe DPT Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe DPT Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific DPT Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific DPT Vaccines Sales by Region (2020-2025) & (M Doses)
Table 37. Asia Pacific DPT Vaccines Sales by Region (2026-2031) & (M Doses)
Table 38. Asia Pacific DPT Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific DPT Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America DPT Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America DPT Vaccines Sales by Country (2020-2025) & (M Doses)
Table 42. Latin America DPT Vaccines Sales by Country (2026-2031) & (M Doses)
Table 43. Latin America DPT Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America DPT Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa DPT Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa DPT Vaccines Sales by Country (2020-2025) & (M Doses)
Table 47. Middle East and Africa DPT Vaccines Sales by Country (2026-2031) & (M Doses)
Table 48. Middle East and Africa DPT Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa DPT Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global DPT Vaccines Sales (M Doses) by Type (2020-2025)
Table 51. Global DPT Vaccines Sales (M Doses) by Type (2026-2031)
Table 52. Global DPT Vaccines Sales Market Share by Type (2020-2025)
Table 53. Global DPT Vaccines Sales Market Share by Type (2026-2031)
Table 54. Global DPT Vaccines Revenue (US$ Million) by Type (2020-2025)
Table 55. Global DPT Vaccines Revenue (US$ Million) by Type (2026-2031)
Table 56. Global DPT Vaccines Revenue Market Share by Type (2020-2025)
Table 57. Global DPT Vaccines Revenue Market Share by Type (2026-2031)
Table 58. Global DPT Vaccines Price (US$/Dose) by Type (2020-2025)
Table 59. Global DPT Vaccines Price (US$/Dose) by Type (2026-2031)
Table 60. Global DPT Vaccines Sales (M Doses) by Age (2020-2025)
Table 61. Global DPT Vaccines Sales (M Doses) by Age (2026-2031)
Table 62. Global DPT Vaccines Sales Market Share by Age (2020-2025)
Table 63. Global DPT Vaccines Sales Market Share by Age (2026-2031)
Table 64. Global DPT Vaccines Revenue (US$ Million) by Age (2020-2025)
Table 65. Global DPT Vaccines Revenue (US$ Million) by Age (2026-2031)
Table 66. Global DPT Vaccines Revenue Market Share by Age (2020-2025)
Table 67. Global DPT Vaccines Revenue Market Share by Age (2026-2031)
Table 68. Global DPT Vaccines Price (US$/Dose) by Age (2020-2025)
Table 69. Global DPT Vaccines Price (US$/Dose) by Age (2026-2031)
Table 70. Sanofi Pasteur Company Information
Table 71. Sanofi Pasteur Description and Business Overview
Table 72. Sanofi Pasteur DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 73. Sanofi Pasteur DPT Vaccines Product
Table 74. Sanofi Pasteur Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 78. GSK DPT Vaccines Product
Table 79. GSK Recent Developments/Updates
Table 80. Mitsubishi Tanabe Pharma Company Information
Table 81. Mitsubishi Tanabe Pharma Description and Business Overview
Table 82. Mitsubishi Tanabe Pharma DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 83. Mitsubishi Tanabe Pharma DPT Vaccines Product
Table 84. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 85. KM Biologics Company Information
Table 86. KM Biologics Description and Business Overview
Table 87. KM Biologics DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 88. KM Biologics DPT Vaccines Product
Table 89. KM Biologics Recent Developments/Updates
Table 90. Wuhan Institute of Biological Products Company Information
Table 91. Wuhan Institute of Biological Products Description and Business Overview
Table 92. Wuhan Institute of Biological Products DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 93. Wuhan Institute of Biological Products DPT Vaccines Product
Table 94. Wuhan Institute of Biological Products Recent Developments/Updates
Table 95. Walvax Biotechnology Company Information
Table 96. Walvax Biotechnology Description and Business Overview
Table 97. Walvax Biotechnology DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 98. Walvax Biotechnology DPT Vaccines Product
Table 99. Walvax Biotechnology Recent Developments/Updates
Table 100. Chengdu Institute of Biological Products Company Information
Table 101. Chengdu Institute of Biological Products Description and Business Overview
Table 102. Chengdu Institute of Biological Products DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 103. Chengdu Institute of Biological Products DPT Vaccines Product
Table 104. Chengdu Institute of Biological Products Recent Developments/Updates
Table 105. Minhai Biotechnology Company Information
Table 106. Minhai Biotechnology Description and Business Overview
Table 107. Minhai Biotechnology DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 108. Minhai Biotechnology DPT Vaccines Product
Table 109. Minhai Biotechnology Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. DPT Vaccines Distributors List
Table 113. DPT Vaccines Customers List
Table 114. DPT Vaccines Market Trends
Table 115. DPT Vaccines Market Drivers
Table 116. DPT Vaccines Market Challenges
Table 117. DPT Vaccines Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of DPT Vaccines
Figure 2. Global DPT Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global DPT Vaccines Market Share by Type: 2024 & 2031
Figure 4. DTaP Product Picture
Figure 5. Tdap Product Picture
Figure 6. DTwP Product Picture
Figure 7. Global DPT Vaccines Market Value by Age (2020-2031) & (US$ Million)
Figure 8. Global DPT Vaccines Market Share by Age: 2024 & 2031
Figure 9. 12 Months Below
Figure 10. 12 Months Above
Figure 11. Global DPT Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global DPT Vaccines Market Size (2020-2031) & (US$ Million)
Figure 13. Global DPT Vaccines Sales (2020-2031) & (M Doses)
Figure 14. Global DPT Vaccines Average Price (US$/Dose) & (2020-2031)
Figure 15. DPT Vaccines Report Years Considered
Figure 16. DPT Vaccines Sales Share by Manufacturers in 2024
Figure 17. Global DPT Vaccines Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest DPT Vaccines Players: Market Share by Revenue in DPT Vaccines in 2024
Figure 19. DPT Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global DPT Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America DPT Vaccines Sales Market Share by Country (2020-2031)
Figure 22. North America DPT Vaccines Revenue Market Share by Country (2020-2031)
Figure 23. United States DPT Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada DPT Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe DPT Vaccines Sales Market Share by Country (2020-2031)
Figure 26. Europe DPT Vaccines Revenue Market Share by Country (2020-2031)
Figure 27. Germany DPT Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France DPT Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. DPT Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy DPT Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia DPT Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific DPT Vaccines Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific DPT Vaccines Revenue Market Share by Region (2020-2031)
Figure 34. China DPT Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan DPT Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea DPT Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India DPT Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia DPT Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan DPT Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia DPT Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand DPT Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia DPT Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America DPT Vaccines Sales Market Share by Country (2020-2031)
Figure 44. Latin America DPT Vaccines Revenue Market Share by Country (2020-2031)
Figure 45. Mexico DPT Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil DPT Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina DPT Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa DPT Vaccines Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa DPT Vaccines Revenue Market Share by Country (2020-2031)
Figure 50. Turkey DPT Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia DPT Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE DPT Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of DPT Vaccines by Type (2020-2031)
Figure 54. Global Revenue Market Share of DPT Vaccines by Type (2020-2031)
Figure 55. Global DPT Vaccines Price (US$/Dose) by Type (2020-2031)
Figure 56. Global Sales Market Share of DPT Vaccines by Age (2020-2031)
Figure 57. Global Revenue Market Share of DPT Vaccines by Age (2020-2031)
Figure 58. Global DPT Vaccines Price (US$/Dose) by Age (2020-2031)
Figure 59. DPT Vaccines Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
